Molecular studies on the protective effect of nicotine in adult-onset hypothyroidism-induced impairment of long-term potentiation

Hippocampus

Volumn 16, Issue 10, 2006, Pages 861-874

  Alzoubi, K H ^a   Aleisa, A M ^b   Alkadhi, Karim A ^a  

^a UNIVERSITY OF HOUSTON   (United States)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Anesthetized rat; Calcineurin; Calmodulin; CaMKII; Hippocampus; Neurogranin; PKC

Indexed keywords

CALCINEURIN; NICOTINE; PHOSPHATASE; PHOSPHOTRANSFERASE; PROTEIN KINASE (CALCIUM,CALMODULIN) II;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME ACTIVITY; HYPOTHYROIDISM; LEARNING DISORDER; LONG TERM CARE; LONG TERM POTENTIATION; MEMORY DISORDER; NEUROPROTECTION; NONHUMAN; ONSET AGE; PRIORITY JOURNAL; RAT;

AGE FACTORS; ANIMALS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CALCINEURIN; CALCIUM; CALMODULIN; DISEASE MODELS, ANIMAL; DOWN-REGULATION; DRUG ADMINISTRATION SCHEDULE; HIPPOCAMPUS; HYPOTHYROIDISM; LONG-TERM POTENTIATION; MALE; MEMORY DISORDERS; NEUROGRANIN; NEUROPROTECTIVE AGENTS; NICOTINE; NICOTINIC AGONISTS; PHOSPHORIC MONOESTER HYDROLASES; PROTEIN KINASE C; RATS; RATS, WISTAR; TIME FACTORS;

EID: 33750434232     PISSN: 10509631     EISSN: 10981063     Source Type: Journal    
DOI: 10.1002/hipo.20217     Document Type: Article

References (66)

1. Aleisa AM, Alzoubi KH, Gerges NZ, Alkadhi KA. 2006a. Chronic psychosocial stress-induced impairment of hippocampal LTP suppression: Possible role of BDNF. Neurobiol Dis 22:453-462.
2. Aleisa AM, Alzoubi KH, Gerges NZ, Alkadhi KA. 2006b. Nicotine blocks stress-induced impairment of spatial memory and long-term potentiation of the hippocampal CA1 region. Int J Neuropsychopharmacol 9:417-426.
3. Alzoubi KH, Gerges NZ, Alkadhi KA. 2005. Levothyroxin restores hypothyroidism-induced impairment of LTP of hippocampal CA1: Electrophysiological and molecular studies. Exp Neurol 195:330-341.
4. Alzoubi KH, Aleisa AM, Alkadhi KA. Nicotine reverses adult onset hypothyroidism-induced impairment of learning and memory: Behavioral and electrophysiological studies. J Neurosci Res (in press).
5. Bancroft A, Levin ED. 2000. Ventral hippocampal α4β2 nicotinic receptors and chronic nicotine effects on memory. Neuropharmacol 39:2770-2778.
6. Barria A, Derkach V, Soderling T. 1997. Identification of the Ca2+/ calmodulin-dependent protein kinase II regulatory phosphorylation site in the α-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate-type glutamate receptor. J Biol Chem 272:32727-32730.
7. Benowitz NL. 1986. Clinical pharmacology of nicotine. Annu Rev Med 37:21-32.
8. Benowitz NL, Jacob P III, Denaro C, Jenkins R. 1991. Stable isotope studies of nicotine kinetics and bioavailability. Clin Pharmacol Ther 49:270-277.
9. Bettany JH, Levin ED. 2001. Ventral hippocampal α 7 nicotinic receptor blockade and chronic nicotine effects on memory performance in the radial-arm maze. Pharmacol Biochem Behav 70:467-474.
10. Cheng G, Rong XW, Feng TP. 1994. Block of induction and maintenance of calcium-induced LTP by inhibition of protein kinase C in postsynaptic neuron in hippocampal CA1 region. Brain Res 646: 230-234.
11. Curran BP, O'Connor JJ. 2003. The inhibition of long-term potentiation in the rat dentate gyrus by pro-inflammatory cytokines is attenuated in the presence of nicotine. Neurosci Lett 344:103-106.
12. Dunne MP, Macdonald D, Hartley LR. 1986. The effects of nicotine upon memory and problem solving performance. Physiol Behav 37:849-854.
13. Fratiglioni L, Wang HX. 2000. Smoking and Parkinson's and Alzheimer's disease: Review of the epidemiological studies. Behav Brain Res 113:117-120.
14. Fujii S, Ji Z, Morita N, Sumikawa K. 1999. Acute and chronic nicotine exposure differentially facilitate the induction of LTP. Brain Res 846:137-143.
15. Fukunaga K, Miyamoto E. 2000. A working model of CaM kinase II activity in hippocampal long-term potentiation and memory. Neurosci Res 38:3-17.
16. Gerendasy DD, Sutcliffe JG. 1997. RC3/neurogranin, a postsynaptic calpacitin for setting the response threshold to calcium influxes. Mol Neurobiol 15:131-163.
17. Gerges NZ, Alkadhi KA. 2004. Hypothyroidism impairs late LTP in CA1 region but not in dentate gyrus of the intact rat hippocampus: MAPK involvement. Hippocampus 14:40-45.
18. Gerges NZ, Stringer JL, Alkadhi KA. 2001. Combination of hypothyroidism and stress abolishes early LTP in the CA1 but not dentate gyrus of hippocampus of adult rats. Brain Res 922:250-260.
19. Gerges NZ, Aleisa AM, Schwarz LA, Alkadhi KA. 2003. Chronic psychosocial stress decreases calcineurin in the dentate gyros: A possible mechanism for preservation of early ltp. Neuroscience 117:869-874.
20. Gerges NZ, Aleisa AM, Schwarz LA, Alkadhi KA. 2004a. Reduced basal CaMKII levels in hippocampal CA1 region: Possible cause of stress-induced impairment of LTP in chronically stressed rats. Hippocampus 14:402-410.
21. Gerges NZ, Alzoubi KH, Park CR, Diamond DM, Alkadhi KA. 2004b. Adverse effect of the combination of hypothyroidism and chronic psychosocial stress on hippocampus-dependent memory in rats. Behav Brain Res 155:77-84.
22. Gerges NZ, Alzoubi KH, Alkadhi KA. 2005. Role of phosphorylated CaMKII and calcineurin in the differential effect of hypothyroidism on LTP of CA1 and dentate gyrus. Hippocampus 15: 480-490.
23. Giese KP, Fedorov NB, Filipkowski RK, Silva AJ. 1998. Autophosphorylation at Thr286 of the α calcium-calmodulin kinase II in LTP, learning. Science 279:870-873.
24. Ho OH, Delgado JY, O'Dell TJ. 2004. Phosphorylation of proteins involved in activity-dependent forms of synaptic plasticity is altered in hippocampal slices maintained in vitro. J Neurochem 91:1344-1357.
25. Huang KP, Huang FL, Jager T, Li J, Reymann KG, Balschun D. 2004. Neurogranin/RC3 enhances long-term potentiation and learning by promoting calcium-mediated signaling. J Neurosci 24:10660-10669.
26. Iniguez MA, Rodriguez-Pena A, Ibarrola N, Aguilera M, Munoz A, Bernal J. 1993. Thyroid hormone regulation of RC3, a brain-specific gene encoding a protein kinase-C substrate. Endocrinology 133:467-473.
27. Ishizuka N, Weber J, Amaral DG. 1990. Organization of intrahippocampal projections originating from CA3 pyramidal cells in the rat. J Comp Neurol 295:580-623.
28. Jacob P III, Benowitz NL, Shulgin AT. 1988. Recent studies of nicotine metabolism in humans. Pharmacol Biochem Behav 30:249-253.
29. Kandel ER. 2001. The molecular biology of memory storage: A dialogue between genes and synapses. Science 294:1030-1038.
30. Krucker T, Siggins GR, McNamara RK, Lindsley KA, Dan A, Allison DW, De Lecea L, Lovenberg TW, Sutcliffe JG, Gerendasy DD. 2002. Targeted disruption of RC3 reveals a calmodulin-based mechanism for regulating metaplasticity in the hippocampus. J Neurosci 22:5525-5535.
31. Laurberg S. 1979. Commissural and intrinsic connections of the rat hippocampus. J Comp Neurol 184:685-708.
32. Le Houezec J, Jacob P III, Benowitz NL. 1993. A clinical pharmacological study of subcutaneous nicotine. Eur J Clin Pharmacol 44: 225-230.
33. Levin ED, Castonguay M, Ellison GD. 1987. Effects of the nicotinic receptor blocker mecamylamine on radial-arm maze performance in rats. Behav Neural Biol 48:206-212.
34. Levin ED, Lee C, Rose JE, Reyes A, Ellison G, Jarvik M, Gritz E. 1990. Chronic nicotine and withdrawal effects on radial-arm maze performance in rats. Behav Neural Biol 53:269-276.
35. Levin ED, Briggs SJ, Christopher NC, Rose JE. 1993a. Chronic nicotinic stimulation and blockade effects on working memory. Behav Pharmacol 4:179-182.
36. Levin ED, Christopher NC, Briggs SJ, Rose JE. 1993b. Chronic nicotine reverses working memory deficits caused by lesions of the fimbria or medial basalocortical projection. Brain Res Cogn Brain Res 1:137-143.
37. Levin ED, Kim P, Meray R. 1996a. Chronic nicotine working and reference memory effects in the 16-arm radial maze: Interactions with D1 agonist and antagonist drugs. Psychopharmacology (Berlin) 127: 25-30.
38. Levin ED, Wilson W, Rose JE, McEvoy J. 19966. Nicotine-haloperidol interactions and cognitive performance in schizophrenics. Neuropsychopharmacology 15:429-436.
39. Levin ED, Christopher NC, Briggs SJ. 1997. Chronic nicotinic agonist and antagonist effects on T-maze alternation. Physiol Behav 61:863-866.
40. Levin ED, Conners CK, Silva D, Hinton SC, Meek WH, March J, Rose JE. 1998. Transdermal nicotine effects on attention. Psychopharmacology (Berlin) 140:135-141.
41. Levin ED, Conners CK, Silva D, Canu W, March J. 2001. Effects of chronic nicotine and methylphenidate in adults with attention deficit/ hyperactivity disorder. Exp Clin Psychopharmacol 9: 83-90.
42. Maggio R, Riva M, Vaglini F, Fornai F, Molteni R, Armogida M, Racagni G, Corsini GU. 1998. Nicotine prevents experimental parkinsonism in rodents and induces striatal increase of neurotrophic factors. J Neurochem 71:2439-2446.
43. Malenka RC, Kauer JA, Zucker RS, Nicoll RA. 1988. Postsynaptic calcium is sufficient for potentiation of hippocampal synaptic transmission. Science 242:81-84.
44. Malenka RC, Kauer JA, Perkel DJ, Mauk MD, Kelly PT, Nicoll RA, Waxham MN. 1989. An essential role for postsynaptic calmodulin and protein kinase activity in long-term potentiation. Nature 340: 554-557.
45. Mansuy IM, Winder DG, Moallem TM, Osman M, Mayford M, Hawkins RD, Kandel ER. 1998. Inducible and reversible gene expression with the rtTA system for the study of memory. Neuron 21:257-265.
46. Mulkey RM, Endo S, Shenolikar S, Malenka RC. 1994. Involvement of a calcineurin/inhibitor-1 phosphatase cascade in hippocampal long-term depression. Nature 369:486-488.
47. Nayak AS, Moore CI, Browning MD. 1996. Cat+/calmodulin-dependent protein kinase II phosphorylation of the presynaptic protein synapsin I is persistently increased during long-term potentiation. Proc Natl Acad Sci USA 93:15451-15456.
48. Newhouse PA, Potter A, Levin ED. 1997. Nicotinic system involvement in Alzheimer's and Parkinson's diseases. Implications for therapeutics. Drugs Aging 11:206-228.
49. Newhouse PA, Potter A, Kelton M, Corwin J. 2001. Nicotinic treatment of Alzheimer's disease. Biol Psychiatry 49:268-278.
50. Norman ED, Thiels E, Barrionuevo G, Klann E. 2000. Long-term depression in the hippocampus in vivo is associated with protein phosphatase-dependent alterations in extracellular signal-regulated kinase. J Neurochem 74:192-198.
51. Pak JH, Huang FL, Li J, Balschun D, Reymann KG, Chiang C, Westphal H, Huang KP. 2000. Involvement of neurogranin in the modulation of calcium/ calmodulin-dependent protein kinase II, synaptic plasticity, and spatial learning: A study with knockout mice. Proc Natl Acad Sci USA 97:11232-11237.
52. Papatheodoropoulos C, Kostopoulos G. 2000. Decreased ability of rat temporal hippocampal CA1 region to produce long-term potentiation. Neurosci Lett 279:177-180.
53. Park S, Knopick C, McGurk S, Meltzer HY. 2000. Nicotine impairs spatial working memory while leaving spatial attention intact. Neuropsychopharmacology 22:200-209.
54. Parrott AC, Winder G. 1989. Nicotine chewing gum (2 mg, 4 mg) and cigarette smoking: Comparative effects upon vigilance and heart rate. Psychopharmacology (Berlin) 97:257-261.
55. Sorenson CA, Raskin LA, Suh Y. 1991. The effects of prenatal nicotine on radial-arm maze performance in rats. Pharmacol Biochem Behav 40:991-993.
56. Sui L, Anderson WL, Gilbert ME. 2005. Impairment in short-term but enhanced long-term synaptic potentiation and ERK activation in adult hippocampal area CA1 following developmental thyroid hormone insufficiency. Toxicol Sci 85:647-656.
57. Tamamaki N, Abe K, Nojyo Y. 1988. Three-dimensional analysis of the whole axonal arbors originating from single CA2 pyramidal neurons in the rat hippocampus with the aid of a computer graphic technique. Brain Res 452:255-272.
58. Thiels E, Kanterewicz BI, Knapp LT, Barrionuevo G, Klann E. 2000. Protein phosphatase-mediated regulation of protein kinase C during long-term depression in the adult hippocampus in vivo. J Neurosci 20:7199-7207.
59. Wang JH, Feng DP. 1992. Postsynaptic protein kinase C essential to induction and maintenance of long-term potentiation in the hippocampal CA1 region. Proc Natl Acad Sci USA 89:2576-2580.
60. Wang JH, Kelly PT. 1995. Postsynaptic injection of CA2+/CaM induces synaptic potentiation requiring CaMKII and PKC activity. Neuron 15:443-452.
61. Wang JH, Kelly PT. 1996. The balance between postsynaptic Ca(2+)-dependent protein kinase and phosphatase activities controlling synaptic strength. Learn Mem 3:170-181.
62. Wang JH, Kelly PT. 1997. Postsynaptic calcineurin activity downregulates synaptic transmission by weakening intracellular Ca2+ signaling mechanisms in hippocampal CA1 neurons. J Neurosci 17: 4600-4611.
63. Wesnes K, Warburton DM. 1984. Effects of scopolamine and nicotine on human rapid information processing performance. Psychopharmacology (Berlin) 82:147-150.
64. White HK, Levin ED. 2004. Chronic transdermal nicotine patch treatment effects on cognitive performance in age-associated memory impairment. Psychopharmacology (Berlin) 171:465-471.
65. Wilson AL, Langley LK, Monley J, Bauer T, Rottunda S, McFalls E, Kovera C, McCarten JR. 1995. Nicotine patches in Alzheimer's disease: Pilot study on learning, memory, and safety. Pharmacol Biochem Behav 51:509-514.
66. Winder DG, Mansuy IM, Osman M, Moallem TM, Kandel ER. 1998. Genetic and pharmacological evidence for a novel, intermediate phase of long-term potentiation suppressed by calcineurin. Cell 92:25-37.